HomeCompareMCK vs IVZ

MCK vs IVZ: Dividend Comparison 2026

MCK yields 0.38% · IVZ yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCK wins by $19.3K in total portfolio value· pulled ahead in Year 7
10 years
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →
IVZ
IVZ
● Live price
3.46%
Share price
$24.29
Annual div
$0.84
5Y div CAGR
-0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$417.94
Full IVZ calculator →

Portfolio growth — MCK vs IVZ

📍 MCK pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCKIVZ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCK + IVZ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCK pays
IVZ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
IVZ
Annual income on $10K today (after 15% tax)
$293.95/yr
After 10yr DRIP, annual income (after tax)
$355.25/yr
At 15% tax rate, MCK beats the other by $8,791.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCK + IVZ for your $10,000?

MCK: 50%IVZ: 50%
100% IVZ50/50100% MCK
Portfolio after 10yr
$34.6K
Annual income
$5,589.65/yr
Blended yield
16.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCK right now

MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
IVZ
Analyst Ratings
12
Buy
16
Hold
Consensus: Hold
Price Target
$30.44
+25.3% upside vs current
Range: $27.00 — $34.50
Altman Z
1.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCK buys
0
IVZ buys
11
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$IVZ▼ Sell$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$IVZ▲ Buy$1,001 - $15,0002026-01-09
Rob Bresnahan🏢 House$IVZ▼ Sell$1,001 - $15,0002025-04-08
Gary Peters🏛 Senate$IVZ▼ Sell$1,001 - $15,0002024-10-17
Ro Khanna🏢 House$IVZ▲ Buy$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$IVZ▼ Sell$1,001 - $15,0002023-10-02
Ro Khanna🏢 House$IVZ▲ Buy$1,001 - $15,0002023-05-23
Ro Khanna🏢 House$IVZ▼ Sell$1,001 - $15,0002022-08-23
Ro Khanna🏢 House$IVZ▼ Sell$1,001 - $15,0002022-06-17
Ro Khanna🏢 House$IVZ▲ Buy$1,001 - $15,0002022-05-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCKIVZ
Forward yield0.38%3.46%
Annual dividend / share$3.28$0.84
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.7%-0.3%
Portfolio after 10y$44.3K$24.9K
Annual income after 10y$10,761.37$417.94
Total dividends collected$22.6K$3.8K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$982.38$30.44

Year-by-year: MCK vs IVZ ($10,000, DRIP)

YearMCK PortfolioMCK Income/yrIVZ PortfolioIVZ Income/yrGap
1$10,764$63.56$11,045$344.78$281.00IVZ
2$11,624$106.59$12,173$354.83$549.00IVZ
3$12,617$179.33$13,389$364.38$772.00IVZ
4$13,803$303.26$14,700$373.45$897.00IVZ
5$15,286$516.89$16,111$382.04$825.00IVZ
6$17,248$891.81$17,629$390.14$381.00IVZ
7← crossover$20,023$1,567.70$19,261$397.78+$762.00MCK
8$24,260$2,835.35$21,014$404.95+$3.2KMCK
9$31,310$5,352.05$22,896$411.66+$8.4KMCK
10$44,263$10,761.37$24,917$417.94+$19.3KMCK

MCK vs IVZ: Complete Analysis 2026

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →

IVZStock

Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients. It launches equity, fixed income, multi-asset, and balanced exchange-traded funds. The firm also launches and manages private funds. It invests in the public equity and fixed income markets across the globe. The firm also invests in alternative markets, such as commodities and currencies. For the equity portion of its portfolio, it invests in growth and value stocks of large-cap, mid-cap, and small-cap companies. For the fixed income portion of its portfolio, the firm invests in convertibles, government bonds, municipal bonds, treasury securities, and cash. It also invests in short term and intermediate term bonds, investment grade and high yield bonds, taxable and tax-free bonds, senior secured loans, and structured securities such as asset-backed securities, mortgage-backed securities, and commercial mortgage-backed securities. The firm employs absolute return, global macro, and long/short strategies. It employs quantitative analysis to make its investments. The firm was formerly known as Invesco Plc, AMVESCAP plc, Amvesco plc, Invesco PLC, Invesco MIM, and H. Lotery & Co. Ltd. Invesco Ltd. was founded in December 1935 and is based in Atlanta, Georgia with an additional office in Hamilton, Bermuda.

Full IVZ Calculator →
📬

Get this MCK vs IVZ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCK vs SCHDMCK vs JEPIMCK vs OMCK vs KOMCK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.